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1. Introduction
Hearing loss can be considered as the most common congenital
disorder in newborns [1]. Early detection and management of
hearing loss is crucial for the developmental period for auditory,
speech and language acquisition of these neonates. Numerous
studies demonstrate that early diagnosis and intervention before
six months of age is effective in allowing children with congenital
hearing loss to acquire age appropriate cognitive and spoken
language skills [2–5]. The potential beneﬁts of early detection can
only be realized if an effective newborn hearing-screening
programme is performed. In Italy [6], as in other developed
countries in the most of birth centres is not present a specialist
audiologist, therefore the neonatal nurse who understands the
consequences of undetected hearing loss is an excellent position to
emphasize the point. In fact it plays an essential role performing
the screening, charting the results and informing the parents about
the screening outcomes.
Among the hearing screening methods, the choice of the
TEOAEs is a simple, quick, effective, non-invasive method and need
using non-specialists without prior audiological experience [7,8].
Even if TEOAE tests are generally thought to be easier to
administer, their main limit is represented by the referral rate
that range from 6% to 12% for the ﬁrst screening [9–11]. According
to Regional Health Department in 2003 we started a NHS pilot
study on well babies in a country of Western Sicily (Sciacca) using
TEOAEs with the purpose of introducing a screen programme with
low-cost protocol and need no specialist control, increasing
options for successful treatment within six months [12]. Aim
project was also to develop an easy and suitable screening
programme comfortable with the current objective hearing
screening technologies, with high sensitivity (the proportion of
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A B S T R A C T
Objective: To determine the feasibility and effectiveness of well-infant nursery hearing screening
programme for the early identiﬁcation of hearing impairment, based on transient evoked otoacoustic
emission (TEOAE) with a high ‘‘screen sensitivity’’ reducing the number of more expensive secondary
level exams.
Methods: The newborns were screened by non-specialist health workers in well babies nursery at the
twentieth day of life for 6 years consecutive. Based on PASS/FAIL criteria and presence/absence of
audiological risk factors the newborns were divided into four groups each one with its personal step
programme: G1 – PASS without risk factor, free to go home; G2 – PASS with risk factor, retest at the age of
7 months; G3 – FAIL without risk factor, re-screening after 2 weeks for a maximum of four times before
audiology assessment; G4 – FAIL with risk factor, retest after 2 weeks.
Results: The coverage rate increased progressively from 89.8% to 92%. The referral rate was 1.51% after
second stage with a speciﬁcity value of 98.78%. The four-stage screening performed for G3 reduced the
numbers of global audiology assessment to 0.91% with a ﬁnal global speciﬁcity of 99.4  0.4%.
Conclusion: Less than 1% of infants underwent audiological assessment; the false positives resulted 0.62%
with hearing loss global incidence of 2.95/1000 and a mean age of conﬁrmation of 3.5 months of age. It is
reasonable to think that this screening programme could be implement to overall 42 Western Sicily birth
centres within few years.
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the children tested with a speciﬁed condition, detected by the
screening protocol) and speciﬁcity (the proportion of the children
tested who do not have a speciﬁed condition who are correctly
identiﬁed by the screen protocol) reducing both the number of
more expensive secondary level exams and the workload of the
only third level speech and hearing centre present in Western
Sicily that represent the effectiveness of UNHS recommended by
JCIH [2].
2. Materials and methods
This study was carried out by the Department of Audiology,
University of Palermo, together with the District of Sciacca,
screening all the newborns of Sciacca hospital from January 2003
to date [12]. The District of Sciacca was chosen for the screening
because in this province there is only a paediatric unit and the
percentage of eligible newborns that were screened before hospital
discharge or within the ﬁrst month of life could have been,
according to quality benchmarks of JCIH, >90%. The urban area of
Sciacca presents a central population of 40.849 according to 2002
census with approximately 1% of newborns per year.
The hearing screening was performed with transient evoked
otoacoustic emission using the PASS-RETEST criteria [13]. The
study protocol was completely explained to parents before
discharge and written informed consent was obtained from each
patient. Data for each subject were collected using a speciﬁc
questionnaire answered by the mothers about the presence of:
family history of permanent childhood hearing impairment, in
utero infections, ototoxic drugs administration, consanguinity. We
also considered as perinatal risk factors: cranio-facial abnormality,
physical ﬁndings such as white forelock, birth weight <1500 g,
slight hyperbilirubinaemia and low Apgar scores [2]. Therefore,
according to the presence/absence of the audiologic risk factors,
the newborns were divided into two groups: newborn with risk
factor and newborn without risk factor. Family Checklists, separate
for babies with or without audiological risk factors, have been
developed as a type of ‘‘roadmap’’ for parents and providers of
newborns, that were also trained on how ‘‘Refer’’ outcomes during
the various stages of screening were not to be presented as
evidence of hearing loss but rather as indication for further tests to
rule out any uncertainty regarding the hearing status of the child;
moreover, to not cause undue anxiety, it was decided to test the
newborns at twentieth day after birth, corresponding to the second
postnatal check without additional cost for ‘maternity unit’ [5,14].
In fact in absence of a specialist screener, and according to data
literature we realized that by subjecting newborns to TEOAEs
before discharge, within three days of life, there was a high
percentage of ‘‘Refer’’ (false positive) also due to moisture, that is
the birth debris and retained ﬂuid in the ear canal [15–18].
The instrument used was the ECHOCHECKTM OAE SCREEANER
by Otodynamics, that is based on the nonlinear cross-correlation
method (ILO88) of TEOAE recording. The TEOAE screening was
conducted by placing a small ILO ECP probe tip from the
ECHOCHECKTM inside the baby’s ear canal; when powered on,
the instrument initiated a routine self-calibration before record-
ings were made. The click rate was approximately 97 per second
and each stimulus (at the probe loud-speaker output) consisted of
a single 80 ms square pulse. To eliminate passive mechanical
artefact from the recorded waveform, stimuli were presented in
blocks of four stimuli: 3 small positive polarity stimuli followed by
one big negative polarity stimulus three times as large. Click peak
stimulus level was 84  3 dB SPL. Emissions elicited from the outer
hair cells in response to the clicks were picked up by the internal
microphone of the equipment and were windowed and ﬁltered to
remove unwanted signals; all response data outside a window from
4 mS to 10 mS, after the stimulus, were removed to eliminate the
stimulus signal. The windowed data was then ﬁltered using 24 dB per
octave Butterworth high and low pass ﬁlters with corner frequencies
of 1.6 kHz and 2.8 kHz, respectively. This ﬁltering preserved the 1.5–
3.0 kHz octave band, in which most of the useful OAE information is
contained. Lower frequencies, which are often contaminated by noise,
and higher frequencies, which are sometimes contaminated by
‘‘ringing’’, were attenuated. The test was based on almost 512
responses recorded after the stimulus, corresponding to a maximum
time of one minute. The ECHOCHECKTM automatically determined the
‘‘pass’’/‘‘fail’’ result based on preset binomial statistical probability
that an emission has been recorded within the frequency range
preserved so the tester/screener could not alter the default settings.
The test was made for three times for each ear, if the ﬁrst one
resulted fail, to value the exam’s repeatability, and was performed
in a sleeping well-fed neonate; no sedation was required. The
instrument was powered by an-inbuilt rechargeable battery that
could last up to 10 h of continuous use. An important quality
control feature of this automated instrument was that every test
was assigned a unique identiﬁcation number which could not be
altered or selectively deleted by the screener until it was
downloaded to the central database after a maximum of 96 tests.
Memory capacity includes date and time, test result, ear tested,
test ID, ear canal size, OAE and noise intensity data. This feature
therefore provided for an independent validation of results
recorded by the screeners for each patient.
Based on both PASS/FAIL criteria and presence/absence of
prenatal and perinatal audiological risk factors the newborns were
divided into four groups: G1 – PASS without risk factor; G2 – PASS
with risk factor; G3 – FAIL without risk factor; G4 – FAIL with risk
factor.
The study was articulated in more steps depending on group
membership; G1: free to go home without advice for the parents;
G2: retest at the age of 7 months and/or diagnostic audiology
assessment by 24–30 months of age; G3: re-screening after 2
weeks for a maximum of four times (four steps programme) and
those who failed were referred for follow-up at the age of 3.5
months to the Tertiary Speech and Hearing Centre; G4: retest after
2 weeks and in case of fail at rescreen the neonate was immediately
send to the Tertiary Speech and Hearing Centre.
The role of the Audiology Section of the Palermo University as
the only third level speech and hearing centre of Western Sicily
was both to assess a global diagnosis by otoacoustic emission
(EOAEs) and auditory brainstem responses (ABR) and to pro-
gramme treatment and rehabilitation of deaf and hearing impaired
children.
Statistical analysis was performed using the Matlab1 computer
program through the means  standard deviation (SD) and the
standard error (SE).
3. Results
The total number of births in the Sciacca hospital during the
period 2003–2008 was 3717; of these 3379 full-term newborns
were tested as out-patients, with a screening coverage rate of 91%.
In particular the newborns born in the hospital of Sciacca in 2003
were 538 and the number of infants whose underwent screening
was 483 (90%) with a 10% (55 neonates) of escaped. In the 2004 the
number of newborns was 653 and 90% of all (585 infants)
underwent screening while 10% (68 neonates) escaped. Of the
overall 666 infants born in 2005, the 90.1% corresponding to 600
newborns were screened. The percentage of screened newborns
increased to 92.7% (547 of the 590 infants) for the 2006. In the
2007, 552 infants, corresponding to 91.2% of the 605 newborns of
Sciacca Hospital were screened. In the last year of the pilot study,
the percentage of screened was 92% corresponding to 612 infants
of the total of 665 newborns. Therefore the percentage of screened
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infants progressively increased from 89.8% for the year 2003 to 92%
for the last year. A total number of 338 newborns were missed; in
particular in 89 cases corresponding to 2.39% of total newborns,
the parents declined screening, while the remaining 249 cases did
not come to the appointment ordered at the dismission.
According to presence/absence of audiological risk factor the
3379 screened were divided into two groups: 331 (9.79%) with
audiological risk factor while 3048 corresponding to 90.21% of the
total screened without risk factor (Table 1).
The number of babies referred at the ﬁrst stage was 123 (3.64%),
99 of whom belong to group G3 (FAIL without risk factor) while 24
resulted G4 (FAIL with risk factor). After second stage the number
of ‘FAIL’ infants was reduced to 51 with a referred percentage value
of 1.51%. Of these 11 infants were with positive audiological risk
factor and were sent to the third level speech and hearing centre
for a global audiological assessment. In ﬁve cases it was diagnosed
a prenatal Sensorineural hearing loss (SNHL), unilateral into 2
cases. The percentage value of deafness among well babies with
audiological risk factor was 1.51%. The 40 ‘FAIL’ infants belong to
G3 underwent a third screening step and, of them 25 babies
resulted refer, and were admitted to a fourth screening step. The
ﬁnal number of G3 babies which underwent to audiological
assessment was of 20 and in 5 cases, corresponding to 0.16% of
total well babies without risk factors a bilateral SNHL was
diagnosed. The workload of the third level speech and hearing
centre was reduced to a total of 31 babies, of whom 21 (0.62%)
resulted false positives (Fig. 1). The global incidence of SNHL,
during the period 2003–2008, was estimated to be 2.95/1000 while
the incidence of bilateral SNHL resulted 2.36/1000. Overall infants
with bilateral deafness had a moderately severe (56–70 dB)
hearing loss and began rehabilitation programme before the age
of ﬁve months.
4. Discussion
The goal of newborn auditory screening is to identify infants
with signiﬁcant hearing impairment in the most rapid and cost-
effective way allowing the opportunity to begin early intervention
services for family with infants. Unfortunately, the ideal hearing-
screening test for children has yet to be deﬁned and local
circumstances may make variations necessary depending on to
medical equipment (ABR or/and EOAEs) and, presence/absence of
audiological specialist [19–21]. This pilot study carried out in
Sciacca hospital from the beginning of 2003, was set out to
determine the feasibility and effectiveness of hospital-based UNHS
by non-specialists for promoting early detection of congenital and
early onset hearing loss in Western Sicily that still now is lacking
[6,12].
It is known that the success of the Newborn Screening
Programme depends upon the coordinated efforts of many health
care professionals; a key role should be represented by neonatal
nurse. In fact, to date in Italy in the most of birth centres is not
present a specialist audiologist, and the task of implement
maternal knowledge and practices regarding audiological risk
factors and implications of a misdiagnosed hearing impairment,
perform the screening, chart the results and inform the parents
about the screening outcomes may led to neonatal nurses [22].
The ‘recommended quality benchmarks by the JCIH’ regarding
the effectiveness of a UNHS focus on the percentage of eligible
newborns that must be screened within the ﬁrst month of life
(90%) [2]. In our pilot study, even if babies underwent screening
in the third week of life, after discharge with a consequent higher
risk of loss from the screen with respect to those screened before
discharge, the coverage rate ranged from 90% to 92.71% with a
mean value of 91% in line with JCHI, comparable to the coverage of
Mexico, Hong Kong, Brazil and higher than those of 85% in
Malaysia, 67% in Oman and 45% in South Africa [14,16,23–26].
The choice of the TEOAE methods is born from the necessity of
create an easy screen test that is functional and need using non-
specialists without prior audiological experience [27,28]; more-
over they are sensitive to lesion sites common to the well-babiesFig. 1. Details of the infants in the four stage programme.
Table 1
Four stage hearing screening programme: details.
Total Mean  SD (SE)
FR
n = 3048
FR+
n = 331
Total
n = 3379
FR
n = 3048
FR+
n = 331
I Step
Pass 2949 307 3256 491.5  54.9 (22.4) 51.2  10.2 (4.2)
Fail 99 24 123 16.5  6.6 (2.7) 4.0  2.5 (1.0)
II Step
Pass 3008 320 3328 501.3  52.0 (21.2) 53.3  10.4 (4.2)
Fail 40 11 51 6.7  1.9 (0.8) 1.8  1.0 (0.4)
III Step
Pass 15 – 15 2.5  1.2 (0.5) 0
Fail 25 – 25 4.2  2.6 (1.0) 0
IV Step
Pass 5 – 5 0.8  0.7 (0.3) 0
Fail 20 – 20 3.3  2.7 (1.1) 0
Audiologic assessment
Pass 15 6 21 2.5  1.9 (0.8) 1.0  0.9 (0.4)
Deaf 5 5 10 0.8  1.0 (0.4) 0.8  0.7 (0.3)
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population, namely those of the cochlea. Even if TEOAE tests are
generally thought to be easier to administer, their main limit is
represented by the referral rate that range from 6% to 12% for the
ﬁrst screening while in case of two-step screen, the TEOAE referral
rate following the second test could drop to 6–7%. On the contrary
AABR tests, that need of specialist control, yield lower ﬁrst-
screening referral rates (1–4%) which drop to 1–2% after the second
screening step [9–11].
To reduce false positive rate using TEOAE, remaining in line
with the percentage suggested by JCIH (4% of newborns that
failed the screening tests before global audiological assessment),
the babies underwent screening at the twenty day of life during the
second postnatal check without additional cost for ‘maternity
unit’; this choose was necessary to eliminate those percentage of
refer due to middle ear ﬂuid, negative ear pressure or debris in the
ear canals that is more common in the ﬁrst days of life and could be
cause of stress parents. After the ﬁrst stage screening in fact, our
overall referral rate was 3.64% with a percentage value of false
positives of only 3.34%; therefore we obtained, just with the ﬁrst
step, lower value than the most TEOAE based screening
programmes from other countries such as Malaysia (12%), South
Africa (11.1%), Oman (11%), Pakistan (10.2%) and Polonia (4.4%)
maintaining a good coverage percentage [7,14,25,26,29]. The
speciﬁcity value after ﬁrst step screening was 96.7  1.6% and, this
percentage increased to 98.78  0.3% after the second stage screening
with a total number of 51 referred, 41 of which false positives (1.21%)
(Table 2).
Usually a hearing screening programme after two referred step
orders a global audiological assessment for a refer newborn [30];
the originality of this experimental protocol is that the infants that
FAIL without audiological risk factor, below to group G3 and most
likely to have a high number of refer, underwent screening 2 weeks
later, for a maximum of four times. This measure, without
additional cost since it was used the same instrumental, allowed
us to lead the total number of newborns admitted to comprehen-
sive audiologic assessment from 51 to 31 newborns with a
percentage value of 0.91% that is more lower than those of 4%
suggested by JCIH; therefore the number of false positives resulted
21 corresponding to 0.62% with a ﬁnal speciﬁcity value of
99.4  0.4% as showed in Table 2. Considering that the birth centres
of all Western Sicily are forty-two, it is easy to understand how this
hearing screening programme articulated with more steps, is able to
strongly reduce the number of false positives, with percentage values
similar to AABR screening programmes [9–11], and consequently the
workload of only tertiary Speech and Hearing Centre of Western
Sicily.
A consideration should be made for the infants belongs to group
G2 who pass the neonatal screening but have a risk factor; overall
these newborns did not require NICU but the possibility of an
hearing loss related to neural conduction disorders or ‘‘auditory
neuropathy/auditory dyssynchrony’’ cannot be excluded [2].
According to JCHI, even if these disorders typically occur in
children who require NICU care, we advised the parents especially
for children with prenatal cytomegalovirus infection, to take care
to infant’s speech-hearing develop and repeating a new test at the
age of 7 months. However to date, after eight years from the
beginning of this pilot study no false negative was identiﬁed.
The mean age of conﬁrmation of hearing loss was of 72 days for
the ﬁve infants below to G4 which after two failed steps were send
immediately to the Tertiary Centre, but at the same time, this
procedure gave to the other deafness infants below to G3 (ﬁve
children), the possibility to undergo an audiologic assessment at
the age of 3.5 months as recommended by ‘‘principles and
guidelines for early hearing detection and intervention programs’’
of the JCIH (2007) [2]. Moreover all the infants with a diagnosis of
SNHL began a rehabilitation programme before the age of 5
months and they have a good speech development and speech
intelligibility; this was the main goal of our pilot study because just
before this newborn hearing screening programme began the
mean age of diagnosed and rehabilitation of hearing loss among
infants born in Sciacca hospital was of 7.2 months.
5. Conclusion
A major ﬁnding in this project was that hospital based universal
newborn hearing screening was feasible in the District of Sciacca
with active cooperation of the hospital staff, neonatal nurses and
caregivers. The study has also demonstrated that TEOAE method
performed at the twentieth day of life is suitable for well babies,
and that non-specialist staff are capable of screening babies’
hearing effectively with minimal training. Moreover the principles
of JCHI have been achieved: the infants underwent hearing
screening within 1 month of age; all the referred children received
an appropriate audiologic and medical evaluations no later than
3.5 months of age; all infants with conﬁrmed permanent hearing
loss have received early intervention services before the age of 5
months. According to Sicilian Regional Health Department it is
reasonable to think that this screening programme could be
implement to overall forty-two Western Sicily birth centres within
few years but it should be necessary that all team members will
work together to ensure that Western Sicily screening programmes
are of high quality and are successful.
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